From a mechanistic point of view, first preclinical studies in MCL and other B-NHL cells co-cultured with stromal cells and macrophages, suggested that the U2 combination may cooperate with the blocking of the CD47 immune checkpoint by regulating genes related with cell architecture [154]. This evidence concerns the gene CD47 and mantle cell lymphoma.